Reported Earnings • May 31
Full year 2026 earnings released: EPS: ₹6.70 (vs ₹12.11 in FY 2025) Full year 2026 results: EPS: ₹6.70 (down from ₹12.11 in FY 2025). Revenue: ₹628.6m (down 5.1% from FY 2025). Net income: ₹69.4m (down 44% from FY 2025). Profit margin: 11% (down from 19% in FY 2025). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Announcement • May 29
Tyche Industries Limited Recommends A Final Dividend for the Year Ended 31 March 2026 Tyche Industries Limited at its board meeting held on 28 May 2026 recommended a final dividend of INR 3.50 per fully paid equity share (35% on the fully paid-up equity share capital of the company) for the year ended 31 March 2026, subject To Approve the shareholders at the ensuing Annual General Meeting. Announcement • May 19
Tyche Industries Limited to Report Q4, 2026 Results on May 28, 2026 Tyche Industries Limited announced that they will report Q4, 2026 results on May 28, 2026 Valuation Update With 7 Day Price Move • May 11
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹140, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 29x in the Pharmaceuticals industry in India. Total loss to shareholders of 28% over the past three years. Reported Earnings • Feb 14
Third quarter 2026 earnings released: EPS: ₹1.78 (vs ₹4.63 in 3Q 2025) Third quarter 2026 results: EPS: ₹1.78 (down from ₹4.63 in 3Q 2025). Revenue: ₹124.3m (down 30% from 3Q 2025). Net income: ₹18.2m (down 62% from 3Q 2025). Profit margin: 15% (down from 27% in 3Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹129, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 28x in the Pharmaceuticals industry in India. Total loss to shareholders of 2.1% over the past three years. Announcement • Feb 05
Tyche Industries Limited to Report Q3, 2026 Results on Feb 12, 2026 Tyche Industries Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 12, 2026 Reported Earnings • Nov 15
Second quarter 2026 earnings released: EPS: ₹1.49 (vs ₹3.90 in 2Q 2025) Second quarter 2026 results: EPS: ₹1.49 (down from ₹3.90 in 2Q 2025). Revenue: ₹168.1m (down 18% from 2Q 2025). Net income: ₹15.2m (down 62% from 2Q 2025). Profit margin: 9.1% (down from 20% in 2Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has remained flat. Announcement • Nov 05
Tyche Industries Limited to Report Q2, 2026 Results on Nov 13, 2025 Tyche Industries Limited announced that they will report Q2, 2026 results on Nov 13, 2025 Board Change • Sep 12
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-Executive Independent Director Venkataraju Kollepalli was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Sep 08
Tyche Industries Limited, Annual General Meeting, Sep 30, 2025 Tyche Industries Limited, Annual General Meeting, Sep 30, 2025, at 11:00 Indian Standard Time. Declared Dividend • Sep 08
Dividend increased to ₹3.00 Dividend of ₹3.00 is 20% higher than last year. Ex-date: 19th September 2025 Payment date: 30th October 2025 Dividend yield will be 2.2%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (25% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to decline by 73% to shift the payout ratio to a potentially unsustainable range, which is more than the 10.0% EPS decline seen over the last 5 years. Reported Earnings • Aug 13
First quarter 2026 earnings released: EPS: ₹2.37 (vs ₹2.66 in 1Q 2025) First quarter 2026 results: EPS: ₹2.37 (down from ₹2.66 in 1Q 2025). Revenue: ₹144.6m (down 6.8% from 1Q 2025). Net income: ₹24.3m (down 11% from 1Q 2025). Profit margin: 17% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has remained flat. Announcement • Aug 02
Tyche Industries Limited to Report Q1, 2026 Results on Aug 12, 2025 Tyche Industries Limited announced that they will report Q1, 2026 results on Aug 12, 2025 Announcement • May 30
Tyche Industries Limited Recommends Final Dividend for the Year Ended March 31, 2025 The board of Tyche Industries Limited in a meeting held on May 28, 2025 considered and approved the recommendation Of final Dividend @ 30% on the fully paid-up Equity Share Capital of the Company that is INR 3.00 per each fully paid equity shares subject to the approval of members in the ensuing Annual General Meeting for the year ended March 31, 2025. Reported Earnings • May 30
Full year 2025 earnings released: EPS: ₹12.19 (vs ₹11.95 in FY 2024) Full year 2025 results: EPS: ₹12.19 (up from ₹11.95 in FY 2024). Revenue: ₹728.9m (up 4.6% from FY 2024). Net income: ₹124.1m (up 1.3% from FY 2024). Profit margin: 17% (in line with FY 2024). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 15
Third quarter 2025 earnings released: EPS: ₹4.63 (vs ₹4.18 in 3Q 2024) Third quarter 2025 results: EPS: ₹4.63 (up from ₹4.18 in 3Q 2024). Revenue: ₹197.9m (down 11% from 3Q 2024). Net income: ₹47.4m (up 11% from 3Q 2024). Profit margin: 24% (up from 19% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹214, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 38x in the Pharmaceuticals industry in India. Total returns to shareholders of 21% over the past three years. Upcoming Dividend • Sep 13
Upcoming dividend of ₹2.50 per share Eligible shareholders must have bought the stock before 20 September 2024. Payment date: 30 October 2024. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 1.4%. Within top quartile of Indian dividend payers (1.0%). Higher than average of industry peers (0.6%). Reported Earnings • Aug 11
First quarter 2025 earnings released: EPS: ₹2.66 (vs ₹2.65 in 1Q 2024) First quarter 2025 results: EPS: ₹2.66 (up from ₹2.65 in 1Q 2024). Revenue: ₹170.4m (flat on 1Q 2024). Net income: ₹27.3m (flat on 1Q 2024). Profit margin: 16% (in line with 1Q 2024). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Announcement • Aug 07
Tyche Industries Limited to Report Q1, 2025 Results on Aug 10, 2024 Tyche Industries Limited announced that they will report Q1, 2025 results at 3:30 PM, Indian Standard Time on Aug 10, 2024 Announcement • May 30
Tyche Industries Limited Recommends Final Dividend Tyche Industries Limited recommended final Dividend at @25% on the fully paid-up Equity Share Capital of the Company that is INR 2.50 per each fully paid equity shares subject to the approval of members in the upcoming Annual General Meeting. Reported Earnings • May 30
Full year 2024 earnings released: EPS: ₹11.78 (vs ₹13.83 in FY 2023) Full year 2024 results: EPS: ₹11.78 (down from ₹13.83 in FY 2023). Revenue: ₹754.3m (flat on FY 2023). Net income: ₹122.4m (down 14% from FY 2023). Profit margin: 16% (down from 19% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 8% per year. Announcement • May 22
Tyche Industries Limited to Report Q4, 2024 Results on May 28, 2024 Tyche Industries Limited announced that they will report Q4, 2024 results on May 28, 2024 Valuation Update With 7 Day Price Move • Apr 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹219, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 33x in the Pharmaceuticals industry in India. Total loss to shareholders of 5.5% over the past three years. Reported Earnings • Feb 14
Third quarter 2024 earnings released: EPS: ₹4.18 (vs ₹4.46 in 3Q 2023) Third quarter 2024 results: EPS: ₹4.18 (down from ₹4.46 in 3Q 2023). Revenue: ₹237.4m (up 19% from 3Q 2023). Net income: ₹42.9m (down 6.1% from 3Q 2023). Profit margin: 18% (down from 23% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 10% per year. Announcement • Feb 03
Tyche Industries Limited to Report Q3, 2024 Results on Feb 12, 2024 Tyche Industries Limited announced that they will report Q3, 2024 results on Feb 12, 2024 Announcement • Sep 12
Tyche Industries Limited Announces Resignation of Boosa Eshwar, Independent Director Tyche Industries Limited announced that Mr. Boosa Eshwar Independent Director of the Company has resigned from the office of Board of the Directors of the Company due to his preoccupations, with effect from close of business hours of September 11, 2023. Announcement • Aug 30
Tyche Industries Limited Approves Dividend on the Equity Shares for the Financial Year Ended March 31, 2023 Tyche Industries Limited held on August 29, 2023, approved declare dividend of 20% i.e. INR 2.00 per share on the equity shares for the financial year ended March 31, 2023. Upcoming Dividend • Aug 15
Upcoming dividend of ₹2.00 per share at 1.2% yield Eligible shareholders must have bought the stock before 22 August 2023. Payment date: 28 September 2023. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.9%). Reported Earnings • Aug 07
Full year 2023 earnings released: EPS: ₹13.83 (vs ₹9.11 in FY 2022) Full year 2023 results: EPS: ₹13.83 (up from ₹9.11 in FY 2022). Revenue: ₹756.0m (up 20% from FY 2022). Net income: ₹141.7m (up 52% from FY 2022). Profit margin: 19% (up from 15% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Announcement • Aug 04
Tyche Industries Limited to Report Q1, 2024 Results on Aug 11, 2023 Tyche Industries Limited announced that they will report Q1, 2024 results on Aug 11, 2023 Announcement • Aug 03
Tyche Industries Limited, Annual General Meeting, Aug 29, 2023 Tyche Industries Limited, Annual General Meeting, Aug 29, 2023, at 11:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March,2023 and together with the Report of the Directors and Auditors Report thereon and; to declare dividend of 20% i.e., INR 2.00 per share on the equity shares for the financial year ended March 31, 2023 and; to appoint a director in the place of Mr. G Sandeep, who retire by rotation and being eligible, offers himself for re appointment; to approve the remuneration payable to cost auditors Mr. Sativada Venkat Rao for the financial year ending 2023-24; and to consider other matters. Announcement • Aug 02
Tyche Industries Limited Announces Management Changes The board of directors of Tyche Industries Limited meeting held on August 1, 2023, approved appointment of Srinivas Gelli as an additional Director of the company in the capacity of Non-Executive Non-Independent Director with immediate effect; taken note the resignation of Mr. Satya Ranjan Jena from the post of company Secretary & Compliance Officer and all other posts he held of the Company with effect from July 31, 2023 closing of business hours; approved appointment of Mr. Pradosh Ranjan Jena as the Company Secretary & Compliance Officer of the company with effect from August 1, 2023; approved change in Designation of Mr. Venkataraju Gupta Kollepalli from Non-Executive Director to Non-Executive Independent Director of the company. Reported Earnings • May 30
Full year 2023 earnings released: EPS: ₹13.74 (vs ₹9.11 in FY 2022) Full year 2023 results: EPS: ₹13.74 (up from ₹9.11 in FY 2022). Revenue: ₹802.1m (up 27% from FY 2022). Net income: ₹141.7m (up 52% from FY 2022). Profit margin: 18% (up from 15% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Announcement • May 28
Tyche Industries Limited Recommends Final Dividend Tyche Industries Limited at its Meeting held on 27th May, 2022 recommended final Dividend at @20% on the fully paid-up Equity Share Capital of the Company that is INR 2.00 per each fully paid equity shares subject to the approval of members in the upcoming Annual General Meeting. Announcement • May 19
Tyche Industries Limited to Report Q4, 2023 Results on May 27, 2023 Tyche Industries Limited announced that they will report Q4, 2023 results on May 27, 2023 Valuation Update With 7 Day Price Move • May 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹204, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 27x in the Pharmaceuticals industry in India. Total returns to shareholders of 99% over the past three years. Reported Earnings • Feb 15
Third quarter 2023 earnings released: EPS: ₹4.46 (vs ₹1.77 in 3Q 2022) Third quarter 2023 results: EPS: ₹4.46 (up from ₹1.77 in 3Q 2022). Revenue: ₹212.5m (up 46% from 3Q 2022). Net income: ₹45.7m (up 152% from 3Q 2022). Profit margin: 22% (up from 12% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Announcement • Feb 03
Tyche Industries Limited to Report Q3, 2023 Results on Feb 13, 2023 Tyche Industries Limited announced that they will report Q3, 2023 results on Feb 13, 2023 Announcement • Oct 22
Tyche Industries Limited to Report Q2, 2023 Results on Nov 10, 2022 Tyche Industries Limited announced that they will report Q2, 2023 results on Nov 10, 2022 Announcement • Oct 14
Tyche Industries Limited Declares Dividend for the Financial Year 2021-22 Tyche Industries Limited declared a dividend of 15% on the face value of equity Shares i-e INR 1.50 per equity share for the financial year 2021-22. The Company has started the payment of the Dividend for the financial year 2021-22 from 10 October, 2022 to all the members whose name appear on the Register of members as on the record date i.e., 23 September 2022. Announcement • Oct 02
Tyche Industries Limited Approves Dividend for the Financial Year Ended March 31, 2022 Tyche Industries Limited announced that at its AGM held on September 30, 2022, the shareholders approved dividend of 15% that is INR 1.50 per share on the equity shares for the financial year ended March 31, 2022. Upcoming Dividend • Sep 15
Upcoming dividend of ₹1.50 per share Eligible shareholders must have bought the stock before 22 September 2022. Payment date: 30 October 2022. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (1.0%). Reported Earnings • Sep 10
Full year 2022 earnings released: EPS: ₹9.11 (vs ₹19.51 in FY 2021) Full year 2022 results: EPS: ₹9.11 (down from ₹19.51 in FY 2021). Revenue: ₹630.2m (down 21% from FY 2021). Net income: ₹93.3m (down 53% from FY 2021). Profit margin: 15% (down from 25% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improved over the past week After last week's 16% share price gain to ₹157, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 23x in the Pharmaceuticals industry in India. Total returns to shareholders of 172% over the past three years. Announcement • Jul 23
Tyche Industries Limited to Report Q1, 2023 Results on Aug 12, 2022 Tyche Industries Limited announced that they will report Q1, 2023 results on Aug 12, 2022 Reported Earnings • Jun 04
Full year 2022 earnings released: EPS: ₹9.17 (vs ₹19.51 in FY 2021) Full year 2022 results: EPS: ₹9.17 (down from ₹19.51 in FY 2021). Revenue: ₹664.2m (down 16% from FY 2021). Net income: ₹93.3m (down 53% from FY 2021). Profit margin: 14% (down from 25% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 31
Tyche Industries Limited Recommends Final Dividend Tyche Industries Limited at its Meeting held on 30 May, 2022 recommended final Dividend at @15% on the fully paid-up Equity Share Capital of the Company that is INR 1.50 per each fully paid equity shares subject to the approval of members in the upcoming Annual General Meeting. Buying Opportunity • Apr 29
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 18%. The fair value is estimated to be ₹182, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has grown by 18%. Buying Opportunity • Mar 29
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 20%. The fair value is estimated to be ₹182, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% per annum over the last 3 years. Earnings per share has grown by 18% per annum over the last 3 years. Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improved over the past week After last week's 16% share price gain to ₹150, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 23x in the Pharmaceuticals industry in India. Total returns to shareholders of 122% over the past three years. Buying Opportunity • Feb 15
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 18%. The fair value is estimated to be ₹183, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% per annum over the last 3 years. Earnings per share has grown by 18% per annum over the last 3 years. Valuation Update With 7 Day Price Move • Feb 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹145, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 23x in the Pharmaceuticals industry in India. Total returns to shareholders of 120% over the past three years. Valuation Update With 7 Day Price Move • Dec 31
Investor sentiment improved over the past week After last week's 26% share price gain to ₹209, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 25x in the Pharmaceuticals industry in India. Total returns to shareholders of 147% over the past three years. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improved over the past week After last week's 15% share price gain to ₹224, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 181% over the past three years. Reported Earnings • Jul 02
Full year 2021 earnings released: EPS ₹19.36 (vs ₹17.14 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹829.8m (up 12% from FY 2020). Net income: ₹199.8m (up 14% from FY 2020). Profit margin: 24% (in line with FY 2020). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 10
Investor sentiment improved over the past week After last week's 18% share price gain to ₹251, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 23x in the Pharmaceuticals industry in India. Total returns to shareholders of 155% over the past three years. Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment improved over the past week After last week's 27% share price gain to ₹224, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 21x in the Pharmaceuticals industry in India. Total returns to shareholders of 116% over the past three years. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improved over the past week After last week's 17% share price gain to ₹181, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 18x in the Pharmaceuticals industry in India. Total returns to shareholders of 70% over the past three years. Valuation Update With 7 Day Price Move • Mar 17
Investor sentiment deteriorated over the past week After last week's 20% share price decline to ₹169, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 19x in the Pharmaceuticals industry in India. Total returns to shareholders of 66% over the past three years. Is New 90 Day High Low • Mar 12
New 90-day low: ₹189 The company is down 12% from its price of ₹214 on 11 December 2020. The Indian market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 1.0% over the same period. Executive Departure • Feb 17
Independent Director has left the company On the 12th of February, Suryanarayana Penumatsa's tenure as Independent Director ended after less than a year in the role. We don't have any record of a personal shareholding under Suryanarayana's name. Suryanarayana is the only executive to leave the company over the last 12 months. Announcement • Feb 13
Tyche Industries Limited Announces Executive Changes Tyche Industries Limited at its board meeting held on 12 February, 2021, approved resignation of Mr. P. Suryanarayana Raju as Director of the Company and appointment of Mr. Venkataraju Gupta Kollepalli as an additional Director of the Company in the capacity of Non-Executive Director with immediate effect. Reported Earnings • Feb 13
Third quarter 2021 earnings released: EPS ₹6.42 (vs ₹4.94 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: ₹248.9m (up 27% from 3Q 2020). Net income: ₹65.8m (up 30% from 3Q 2020). Profit margin: 26% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Announcement • Feb 02
Tyche Industries Limited to Report Q3, 2021 Results on Feb 12, 2021 Tyche Industries Limited announced that they will report Q3, 2021 results on Feb 12, 2021 Is New 90 Day High Low • Dec 21
New 90-day low: ₹201 The company is down 27% from its price of ₹275 on 22 September 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 7.0% over the same period. Is New 90 Day High Low • Nov 12
New 90-day low: ₹227 The company is down 5.0% from its price of ₹238 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is flat over the same period. Announcement • Oct 01
Tyche Industries Limited Approves the Change in Designation of P. Vijaya Lakshmi from Non-Executive Director to Non-Executive Independent Director Tyche Industries Limited at the AGM held on September 30, 2020, approved the change in designation of Mrs. P. Vijaya Lakshmi from non-executive director to non-executive independent director of the company.